Lupin Completes VISUfarma Acquisition, Expands Eye Care Portfolio to 60+ Products
Published on: April 2, 2026, 11:27 a.m. | Source: scanx.trade
Lupin Limited successfully completed its strategic acquisition of VISUfarma B.V., a European specialty pharmaceutical company, through its Netherlands subsidiary Nanomi B.V. The transaction adds over 60 branded eye care products spanning dry eye, glaucoma, and retinal health segments, while bringing €53 million in revenue and strengthening Lupin's commercial footprint across key European markets including Italy, UK, Spain, Germany, and France.
